Your browser doesn't support javascript.
loading
Survival benefit of using pemetrexed for EGFR mutation-positive advanced non-small-cell lung cancer in a randomized phase III study comparing gefitinib to cisplatin plus docetaxel (WJTOG3405).
Haratake, Naoki; Shimokawa, Mototsugu; Seto, Takashi; Yoshioka, Hiroshige; Yamamoto, Nobuyuki; Nakagawa, Kazuhiko; Mitsudomi, Tetsuya.
  • Haratake N; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Shimokawa M; Department of Thoracic Oncology, National Hospital Organization, Kyushu Cancer Center, 3-1-1 Notame, Minami-ku, Fukuoka, 811-1395, Japan.
  • Seto T; Department of Biostatistics, Graduate School of Medicine, Yamaguchi University, Yamaguchi, Japan.
  • Yoshioka H; Department of Thoracic Oncology, National Hospital Organization, Kyushu Cancer Center, 3-1-1 Notame, Minami-ku, Fukuoka, 811-1395, Japan. setocruise@gmail.com.
  • Yamamoto N; Department of Thoracic Oncology, Kansai Medical University Hospital, Hirakata, Japan.
  • Nakagawa K; Internal Medicine III, Wakayama Medical University Hospital, Wakayama, Japan.
  • Mitsudomi T; Department of Medical Oncology, Kindai University Hospital, Osaka-Sayama, Japan.
Int J Clin Oncol ; 27(9): 1404-1412, 2022 Sep.
Article en En | MEDLINE | ID: mdl-35723758
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article